TKNO Alpha Teknova, Inc.

Alpha Teknova, Inc. provides reagents for bioprocessing, bioproduction, and molecular diagnostics. The company's reagents enable the discovery, research, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. It offers liquid culture, dry culture, agar, and animal-free media, as well as pre-poured plates, biological buffers, solutions, chemicals, and various treated and certified waters. The company was founded in 1996 and is based in Hollister, California.

As of 12/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  07/25/1994
Outstanding shares:  28,090,484
Average volume:  62,395
Market cap:   $130,339,846
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BP7L561
Valuation   (See tab for details)
PE ratio:   -9.05
PB ratio:   0.96
PS ratio:   3.35
Return on equity:   -10.57%
Net income %:   -37.59%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy